Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice

By sjmartinez • September 27, 2023

Teper Y, Ye L, Waldron RT, Lugea A, Sun X, Sinnett-Smith J, Hines OJ, Pandol SJ, Rozengurt E, Eibl G. Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice. Sci Rep. 2023 Sep 26;13(1):16144. doi: 10.1038/s41598-023-43498-9. PMID: 37752238.

Tags: Cedars Sinai DoM, Digestive Diseases, Publications

Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction

Naghavi M, Reeves AP, Atlas K, Zhang C, Atlas T, Henschke CI, Yankelevitz DF, Budoff MJ, Li D, Roy SK, Nasir K, Molloi S, Fayad[...]

Machine learning-based clustering identifies obesity subgroups with differential multi-omics profiles and metabolic patterns

Anwar MY, Highland H, Buchanan VL, Graff M, Young K, Taylor KD, Tracy RP, Durda P, Liu Y, Johnson CW, Aguet F, Ardlie KG, Gerszten[...]

Clinical Correlates of a Single-item Physical Activity Questionnaire among Patients Undergoing Stress SPECT Myocardial Perfusion Imaging

Rozanski A, Gransar H, Miller RJ, Han D, Hayes S, Friedman J, Thomson L, Berman D. Clinical Correlates of a Single-item Physical Activity Questionnaire among[...]